Aerovate Therapeutics Inc (AVTE)
21.75
+0.18
(+0.83%)
USD |
NASDAQ |
Apr 26, 16:00
21.82
+0.07
(+0.32%)
After-Hours: 20:00
Aerovate Therapeutics Market Cap: 606.02M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 606.02M |
| April 25, 2024 | 601.00M |
| April 24, 2024 | 590.70M |
| April 23, 2024 | 646.98M |
| April 22, 2024 | 617.72M |
| April 19, 2024 | 614.38M |
| April 18, 2024 | 601.84M |
| April 17, 2024 | 626.92M |
| April 16, 2024 | 658.12M |
| April 15, 2024 | 704.93M |
| April 12, 2024 | 703.26M |
| April 11, 2024 | 749.24M |
| April 10, 2024 | 752.58M |
| April 09, 2024 | 781.56M |
| April 08, 2024 | 737.81M |
| April 05, 2024 | 697.97M |
| April 04, 2024 | 810.81M |
| April 03, 2024 | 811.37M |
| April 02, 2024 | 824.19M |
| April 01, 2024 | 856.79M |
| March 28, 2024 | 823.91M |
| March 27, 2024 | 794.10M |
| March 26, 2024 | 714.69M |
| March 25, 2024 | 750.91M |
| March 22, 2024 | 718.31M |
| Date | Value |
|---|---|
| March 21, 2024 | 724.44M |
| March 20, 2024 | 718.78M |
| March 19, 2024 | 714.06M |
| March 18, 2024 | 732.66M |
| March 15, 2024 | 741.26M |
| March 14, 2024 | 674.36M |
| March 13, 2024 | 749.04M |
| March 12, 2024 | 670.19M |
| March 11, 2024 | 687.68M |
| March 08, 2024 | 736.27M |
| March 07, 2024 | 677.41M |
| March 06, 2024 | 662.70M |
| March 05, 2024 | 634.10M |
| March 04, 2024 | 624.38M |
| March 01, 2024 | 661.59M |
| February 29, 2024 | 640.76M |
| February 28, 2024 | 641.04M |
| February 27, 2024 | 659.92M |
| February 26, 2024 | 575.80M |
| February 23, 2024 | 544.98M |
| February 22, 2024 | 522.49M |
| February 21, 2024 | 523.33M |
| February 20, 2024 | 521.94M |
| February 16, 2024 | 580.52M |
| February 15, 2024 | 600.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
201.39M
Minimum
Jan 21 2022
856.79M
Maximum
Apr 01 2024
443.86M
Average
437.92M
Median
Mar 30 2022
Market Cap Benchmarks
| Insmed Inc | 3.683B |
| Annexon Inc | 423.12M |
| CEL-SCI Corp | 77.73M |
| AIM ImmunoTech Inc | 21.37M |
| IGC Pharma Inc | 29.19M |
Market Cap Related Metrics
| Price to Book Value | 5.537 |
| Price | 21.75 |
| Earnings Yield | -13.24% |